Patents Assigned to GENERON (SHANGHAI) CORPORATION
-
Patent number: 11660565Abstract: A device for separating a gas, such as air, into components, includes a plurality of modules, each module having one or more polymeric membranes capable of gas separation. A set of valves, pipes, and manifolds together arrange the modules in one of two possible configurations. In a first configuration, the modules are arranged in parallel. In a second configuration, the modules are divided into two groups which are arranged in series. The device can be switched from parallel to series, or from series to parallel, simply by changing the positions of a small number of valves, typically three valves. The device can therefore produce gas either of higher purity, or moderate purity, depending on the settings of the valves. The device also includes improved structures for connecting the modules to inlet and outlet manifolds, and also includes devices for temporarily isolating one or more modules from the system.Type: GrantFiled: October 14, 2020Date of Patent: May 30, 2023Assignee: Generon IGS, Inc.Inventors: Steven Reese, Marc Straub, John A. Jensvold, Robert Kociolek
-
Patent number: 11654401Abstract: A cartridge for non-cryogenically separating a gas into components includes a plurality of hollow polymeric fibers, the fibers being anchored by a pair of tubesheets, each tubesheet being adjacent to a head, the tubesheet and head being joined by a clamshell retainer. The cartridge does not have a core tube. The fibers are enclosed within a sleeve, the sleeve being sufficiently thin so as to be a non-structural element. The cartridge may be inserted within a larger pressure vessel. The cartridge of the present invention can accommodate more fibers than comparable cartridges of the prior art, and therefore has greater throughput.Type: GrantFiled: October 25, 2021Date of Patent: May 23, 2023Assignee: Generon IGS, Inc.Inventors: Robert Kociolek, Marc Straub, Frederick L. Coan, Luis Brizuela, John A. Jensvold, Kyle Jensvold, Karen Skala
-
Patent number: 11446610Abstract: A gas separation module includes hollow polymeric fibers held between a pair of tubesheets. The tubesheets are mounted to a core tube, and the distance between the tubesheets is maintained constant. The core tube is formed in telescoping sections, such that the fibers are attached to the tubesheets when the core tube is in its extended position, and the core tube is then collapsed, forming slack in the fibers. The core tube includes two distinct channels, connected to receive permeate and retentate gas streams, and to carry these streams to outlet ports while keeping the streams separate. Because the tubesheets are affixed to the core tube, the tubesheets do not move under the influence of gas pressure in the module. The slack in the fibers compensates for shrinkage of the fibers, prolonging the life of the module.Type: GrantFiled: March 3, 2020Date of Patent: September 20, 2022Assignee: Generon IGS, Inc.Inventors: Marc Straub, Robert Kociolek, Frederick L. Coan, Luis Brizuela
-
Patent number: 11103827Abstract: A two-stage gas-separation membrane system includes two identical membrane modules held within a single casing. A feed gas is directed into the first module, so as to produce permeate and retentate streams. One of the latter streams then becomes the feed gas for the second module, and reaches the second module through a core tube located within the module. The product of the second module is the product gas for the system. The gas streams entering the two modules flow in mutually opposite directions. This arrangement makes it feasible to provide a two-stage system while using only the number of ports that would be needed for a single stage.Type: GrantFiled: January 8, 2020Date of Patent: August 31, 2021Assignee: Generon IGS, Inc.Inventors: Frederick L. Coan, John A. Jensvold, Robert Kociolek, Marc Straub
-
Publication number: 20210138038Abstract: The present invention provides methods and compositions for the use of IL-22 for treating conditions of intestinal injury and inflammatory conditions such as graft vs. host disease. Specifically, IL-22 can be used to increase Intestinal Stem Cell (ISC) recovery and for enhancing immune reconstitution following allogeneic hematopoietic transplantation. In particularly preferred embodiments, the present invention provides methods of using therapeutic IL-22, including a dimeric form of IL-22, in therapeutic compositions for treating graft vs. host disease, including hepatic, thymic, gastrointestinal, or other graft vs. host disease in hematopoietic stem cell transplant patients and in patients with inflammatory intestinal conditions.Type: ApplicationFiled: December 23, 2019Publication date: May 13, 2021Applicants: MEMORIAL SLOAN-KETTERING CANCER CENTER, GENERON (SHANGHAI) CORPORATION, LTD.Inventors: Marcel VAN DEN BRINK, Alan HANASH, Caroline LINDEMANS, Tom TANG
-
Patent number: 10933369Abstract: An air dehydration module includes polymeric fibers for separating water vapor from air, and also includes a carbon filter material, positioned at an outlet end of the module, and within the same pressure vessel which houses the fibers. The module may generate its own sweep stream, in which case a portion of its output is directed to flow through an orifice, towards the inlet end of the module. In an alternative embodiment, the sweep gas is produced by a distinct gas-separation module, which receives an input stream from the output of the dehydration module. The dehydration module produces clean and dry air which can be used as is, or as an input stream to an air separation module.Type: GrantFiled: May 25, 2018Date of Patent: March 2, 2021Assignee: Generon IGS, Inc.Inventors: Marc Straub, Luis Brizuela, John A. Jensvold
-
Patent number: 10870701Abstract: The present invention provides multispecific Fab fusion proteins (MSFP) that specifically bind to CD3 and EpCAM. The present invention further provides uses of the MSFPs for the preparation of pharmaceutical compositions, methods of treating cancer, and kits comprising the MSFPs. Also provided are anti-EpCAM antibodies or antigen-binding fragments thereof.Type: GrantFiled: March 15, 2017Date of Patent: December 22, 2020Assignee: Generon (Shanghai) Corporation Ltd.Inventors: Yumin Cui, Zhihua Huang, Hanyang Chen, Xinfeng Zhang, Bo Qi, Xiaoqiang Yan
-
Patent number: 10843127Abstract: A device for separating a gas, such as air, into components, includes a plurality of modules, each module having one or more polymeric membranes capable of gas separation. A set of valves, pipes, and manifolds together arrange the modules in one of two possible configurations. In a first configuration, the modules are arranged in parallel. In a second configuration, the modules are divided into two groups which are arranged in series. The device can be switched from parallel to series, or from series to parallel, simply by changing the positions of a small number of valves, typically three valves. The device can therefore produce gas either of higher purity, or moderate purity, depending on the settings of the valves.Type: GrantFiled: October 12, 2018Date of Patent: November 24, 2020Assignee: Generon IGS, Inc.Inventors: Steven Reese, Marc Straub, John A. Jensvold
-
Patent number: 10786551Abstract: The present invention relates to use of interleukin-22 (IL-22) for treating fatty liver disease by decreasing the levels of transaminases. The use of IL-22 in decreasing the levels of transaminases is also provided.Type: GrantFiled: September 1, 2017Date of Patent: September 29, 2020Assignee: Generon (Shanghai) Corporation Ltd.Inventors: Yu Liang Huang, Zhi Hua Huang, Qi Sun
-
Patent number: 10561978Abstract: A multi-stage polymeric membrane module system separates a gas, such as air, into components of high purity. In at least two of the stages, a portion of the retentate gas is directed into the low-pressure side of the module, to act as a sweep gas. The use of the sweep gas reduces the partial pressure of permeate gas on the low-pressure side of the membrane, and therefore improves the flow of permeate through the membrane. In a preferred embodiment, there are three modules. The output streams are taken from the retentate outlet of one module, and from the permeate outlet of another module. The output streams have very high purity, relative to the number of modules required, as compared with systems of the prior art.Type: GrantFiled: February 13, 2018Date of Patent: February 18, 2020Assignee: Generon IGS, Inc.Inventors: John A. Jensvold, Kyle A. Jensvold
-
Patent number: 10543169Abstract: The present application provides methods of administering an IL-22 dimer to an individual, such as a human individual, comprising intravenously administering to the individual an effective amount of an IL-22 dimer, wherein the amount of the IL-22 dimer is about 2 ?g/kg to about 200 ?g/kg (such as about 10 ?g/kg to about 45 ?/kg), as well as methods of treating diseases by following such administration methods. Also provided are kits, unit dosages, and articles of manufacture for use in any one of the methods described herein.Type: GrantFiled: November 6, 2014Date of Patent: January 28, 2020Assignee: Generon (Shanghai) Corporation Ltd.Inventors: Xiaoqiang Yan, Cheng Huang, Dongdong Wu, Kaiyang Tang, Yuliang Huang
-
Patent number: 9987600Abstract: A polymeric fiber for use in gas separation is formed from a spin dope which includes solvent and non-solvent materials. The fiber is passed through a quench bath, and then a leach bath, in which the solvent and non-solvent are removed. The quench bath and the leach bath include sets of rollers which transport the fiber through the system. Each set of rollers in the leach bath operates at a speed which is greater than or equal to the speed of the rollers which are immediately upstream. Thus, the fiber is stretched, in different amounts, at the same time that the solvent and non-solvent are being removed, and while the fiber is still wet. The resulting fiber has been found to exhibit superior flux and selectivity properties.Type: GrantFiled: March 28, 2014Date of Patent: June 5, 2018Assignee: Generon IGS, Inc.Inventors: Frederick L. Coan, Arthur J. Barajas, Jeff C. Schletz
-
Patent number: 9764275Abstract: A module having polymeric gas-separation membranes is capable of operation in extreme temperature environments. In one embodiment, the module includes polymeric fiber membranes, a tubesheet for holding the membranes, and a sleeve encasing the membranes, all of which are made of materials having coefficients of thermal expansion which differ from each other by not more than about 10%. In another embodiment, the membranes, the tubesheet, and the sleeve are all made of materials having a glass transition temperature greater than a highest anticipated temperature of operation of the module. In another embodiment, the module includes a head, and a clamshell having multiple protrusions which engage corresponding grooves in the head and in at least two grooves formed in the tubesheet.Type: GrantFiled: June 22, 2015Date of Patent: September 19, 2017Assignee: Generon IGS, Inc.Inventors: Jeff C. Schletz, Frederick L. Coan, Karen Skala, Marc Straub, Kyle A. Jensvold, John A. Jensvold, Luis Brizuela
-
Patent number: 9642917Abstract: The invention discloses the use of the G-CSF dimer in the preparation of a medicament for the treatment of neurodegenerative diseases. Use of the G-CSF dimer of the present invention can significantly increase the number of dopaminergic neuron in the substantia nigra in PD model animals and enhance the function of dopaminergic neurons. In addition, the G-CSF dimer can significantly reduce apoptosis of neuron in hippocampus and improve learning and memory ability of AD model rats. Serum half-life of the G-CSF dimer of the invention is prolonged and the loss of neurons is effectively prevented, providing a better therapeutic effect in treatment of neurodegenerative disease.Type: GrantFiled: July 24, 2012Date of Patent: May 9, 2017Assignee: GENERON (SHANGHAI) CORPORATION, LTD.Inventors: Dong-Dong Wu, Zhihua Huang, Yuliang Huang, Xiaoqiang Yan
-
Patent number: 9629898Abstract: This invention relates to a use of IL-22 in the treatment of viral hepatitis. As illustrated in the examples of this invention, IL-22 can significantly reduce liver damage caused by hepatitis virus, and can significantly reduce the increase of transaminase ALT/AST induced by heptatitis virus. In addition, the IL-22 dimer of this invention can effectively treat viral hepatitis.Type: GrantFiled: December 16, 2014Date of Patent: April 25, 2017Assignee: Generon (Shanghai) Corporation, LTD.Inventors: Xiaoqiang Yan, Zhihua Huang, Hongzhou Yang, Yuliang Huang
-
Patent number: 9545599Abstract: A gaseous component is extracted non-cryogenically from a feed gas containing condensable hydrocarbons. The feed gas is passed first through a module containing polymeric fibers useful for removing water vapor from the gas. The gas is then passed through a module containing polymeric fibers selected such that they remove some, but not all, of the carbon dioxide in the stream. The gas is then passed through a module containing polymeric fibers selected to remove at least some of the remaining carbon dioxide as well as heavy hydrocarbons, defined as C5 and heavier, from the stream. The invention is especially useful in processing raw methane taken from a well, and in producing methane which is relatively free of water vapor, carbon dioxide, and heavy hydrocarbons.Type: GrantFiled: January 15, 2014Date of Patent: January 17, 2017Assignee: Generon IGS, Inc.Inventors: Marc Straub, John A. Jensvold
-
Patent number: 9352024Abstract: This invention discloses the uses of IL-22 in the treatment and prevention of a nerve damage disease or a neurodegenerative disease. In particular, the invention discloses the uses of IL-22 or IL-22 dimers as follows: (i) can protect neurons to recover the functions of injured neurons after ischemic nerve damage in animals in vivo, thus enabling effective treatment of nerve damage diseases, (ii) can significantly inhibit the loss of dopaminergic neurons in substantia nigra in PD model animal, enhance the functions of dopaminergic neurons, significantly reduce neuronal apoptosis in hippocampus, improve learning and memory capacity of AD model rats, and effectively prevent neuronal loss, thereby enabling more effective treatment of neurodegenerative diseases.Type: GrantFiled: December 27, 2012Date of Patent: May 31, 2016Assignee: Generon (Shanghai) Corporation LTD.Inventors: Dongdong Wu, Zhihua Huang, Heng Liu, Yuliang Huang, Xiaoqiang Yan
-
Patent number: 9273108Abstract: This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be restored. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased.Type: GrantFiled: August 30, 2013Date of Patent: March 1, 2016Assignee: Generon (Shanghai) Corporation Ltd.Inventors: Xiaoqiang Yan, Zhihua Huang, Hongzhou Yang, Bill N. C. Sun, Yuliang Huang
-
Publication number: 20150202267Abstract: This invention relates to a use of IL-22 in the treatment of viral hepatitis. As illustrated in the examples of this invention, IL-22 can significantly reduce liver damage caused by hepatitis virus, and can significantly reduce the increase of transaminase ALT/AST induced by heptatitis virus. In addition, the IL-22 dimer of this invention can effectively treat viral hepatitis.Type: ApplicationFiled: December 16, 2014Publication date: July 23, 2015Applicant: Generon (Shanghai) Corporation, LTD.Inventors: Xiaoqiang YAN, Zhihua HUANG, Hongzhou YANG, Yuliang HUANG
-
Patent number: 9034957Abstract: A composition for making polymeric fiber membranes, for use in non-cryogenic separation of gases, substantially improves product flow, with only a small decrease in the recovery ratio. The composition is a spin dope including tetrabromo bis-phenol A polycarbonate (TBBA-PC) and tetrabromo bishydroxyphenylfluorene polycarbonate (TBBHPF-PC), in proportions, by weight, ranging (in percent) from about 60/40 to 40/60, and n-methyl pyrrolidinone (NMP) and triethylene glycol (TEG), wherein the ratio of the amounts of NMP to TEG, by weight, is in the range of about 1.6-2.5. The spin dope is used to make hollow fibers for use in gas-separation membrane modules.Type: GrantFiled: October 16, 2013Date of Patent: May 19, 2015Assignee: Generon IGS, Inc.Inventors: John A. Jensvold, Frederick L. Coan, Arthur J. Barajas